Myriam Guiral
in the press
Scientific appointments, podcast appearances, and institutional recognition for Myriam Guiral’s work at the intersection of oncology, digital health, and leadership.
“Nothing is impossible. Everything can happen — you must hold on, trust yourself, and surround yourself with the right people.” Myriam Guiral — Parlons de votre Mental, World Cancer Day 2025
Institutional appointments
Inaugural Member, NETRI Scientific Advisory Board
Named one of two founding members of NETRI’s SAB, Myriam contributes expertise in oncology and pain management. Her mandate focuses on advancing chip-based models of chemotherapy-induced peripheral neuropathy and identifying key business opportunities in organ-on-chip technology.
Read the announcement →NETRI Establishes Scientific Advisory Board in Oncology
The Gazette du Labo reported on NETRI’s newly formed SAB, covering the first meeting where Myriam Guiral and Dr. Nicolas Aznar addressed the state of the art in oncology and 3D cell culture, including organoid research directions.
Read the article →Parlons de votre Mental
Scientist, executive, and expert patient — founding MG Innovate & RESILIO Health
A wide-ranging conversation covering Myriam’s PhD on chemotherapy resistance in breast cancer, 25 years of executive leadership, her 2023 diagnosis, and the journey that led her to found MG Innovate and RESILIO Health. Also covers Team Phoenix — a desert challenge in Senegal raising funds for breast cancer screening in Africa.
Resilience and Cancer: Myriam Guiral shares her story for World Cancer Day
Published on February 4, 2025 for World Cancer Day, this episode features Myriam’s lived experience with cancer, the mental strategies that guided her through diagnosis and treatment, and how she now channels that experience into supporting health and innovation startups.
LinkedIn coverage
Impact Oncologie partnership announcement
A post announced a strategic partnership involving MG Innovate’s work in oncology impact, shared widely within the French health innovation and medtech community.
View on LinkedIn →NETRI announces Myriam Guiral to its Scientific Advisory Board
The official LinkedIn announcement of Myriam Guiral’s SAB appointment reached the French biotech and digital health network, reinforcing her standing as a key opinion leader in oncology innovation.
View on LinkedIn →Invite Myriam to speak or collaborate
Available for expert panels, podcast interviews, consulting engagements, and keynote speaking on digital health, oncology innovation, and resilient leadership.
Get in touch